FR2150903A1 - - Google Patents

Info

Publication number
FR2150903A1
FR2150903A1 FR7230504A FR7230504A FR2150903A1 FR 2150903 A1 FR2150903 A1 FR 2150903A1 FR 7230504 A FR7230504 A FR 7230504A FR 7230504 A FR7230504 A FR 7230504A FR 2150903 A1 FR2150903 A1 FR 2150903A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7230504A
Other languages
French (fr)
Other versions
FR2150903B1 (enExample
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sterwin AG
Original Assignee
Sterwin AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterwin AG filed Critical Sterwin AG
Publication of FR2150903A1 publication Critical patent/FR2150903A1/fr
Application granted granted Critical
Publication of FR2150903B1 publication Critical patent/FR2150903B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR7230504A 1971-08-27 1972-08-28 Expired FR2150903B1 (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4042771A GB1390032A (en) 1971-08-27 1971-08-27 Pharmaceutical compositions

Publications (2)

Publication Number Publication Date
FR2150903A1 true FR2150903A1 (enExample) 1973-04-13
FR2150903B1 FR2150903B1 (enExample) 1975-10-17

Family

ID=10414863

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7230504A Expired FR2150903B1 (enExample) 1971-08-27 1972-08-28

Country Status (7)

Country Link
AU (1) AU4584572A (enExample)
CA (1) CA988424A (enExample)
DE (1) DE2241960C2 (enExample)
DK (1) DK131418B (enExample)
FR (1) FR2150903B1 (enExample)
GB (1) GB1390032A (enExample)
ZA (1) ZA725791B (enExample)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0040472A3 (en) * 1980-05-20 1982-07-21 Mallinckrodt, Inc. Spray dried n-acetyl-p-aminophenol compositions and method for manufacture thereof
EP0186090A3 (en) * 1984-12-24 1987-09-02 Basf Aktiengesellschaft Process for the preparation of an ascorbic-acid granulate
EP0305051A1 (en) * 1987-07-27 1989-03-01 McNeilab, Inc. Orally sustained-release acetaminophen formulation and process to obtain it
EP0255725A3 (en) * 1986-08-06 1991-01-30 Eisai Co., Ltd. Sustained-release multi-granule tablet
WO1994020086A1 (en) * 1993-03-12 1994-09-15 British Technology Group Limited Pharmaceutical compositions comprising paracetamol and l-cysteine or a precursor thereof

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR226763A1 (es) * 1980-12-22 1982-08-13 Monsanto Co Metodo de preparacion de una granulacion analgesica de acetaminofeno
DE3215211A1 (de) * 1982-04-23 1983-10-27 Akzo Gmbh Mikroporoese mit wirkstoffen beladene pulver
US4562024A (en) * 1982-07-06 1985-12-31 Sterling Drug Inc. Process for preparing granulate containing poorly compressible medicinally active matter
NO832446L (no) * 1982-07-06 1984-01-30 Sterwin Ag, Fremgangsmaate ved fremstilling av tabletter.
US4600579A (en) * 1983-06-07 1986-07-15 Mallinckrodt, Inc. N-acetyl-p-aminophenol compositions containing partially gelatinized starch and method for preparing same
US4684516A (en) * 1983-08-01 1987-08-04 Alra Laboratories, Inc. Sustained release tablets and method of making same
US4661521A (en) * 1984-04-30 1987-04-28 Mallinckrodt, Inc. Direct tableting acetaminophen compositions
US4631284A (en) * 1984-11-19 1986-12-23 Mallinckrodt, Inc. Acetaminophen compositions containing low doses of chlorpheniramine maleate, method for preparing same and tablets formed therefrom
US4757090A (en) * 1986-07-14 1988-07-12 Mallinckrodt, Inc. Direct tableting acetaminophen compositions
US4837031A (en) * 1987-09-17 1989-06-06 Mallinckrodt, Inc. Compositions containing ibuprofen
DE19835124C2 (de) * 1998-08-04 2002-01-03 Buna Sow Leuna Olefinverb Gmbh Verfahren zur Herstellung von Stärkeestern mit definierter Kornstruktur für pharmazeutische Zwecke
EP3175844A1 (en) 2010-04-09 2017-06-07 Pacira Pharmaceuticals, Inc. Large diameter synthetic membrane vesicles

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3200039A (en) * 1962-05-28 1965-08-10 Pfizer & Co C Non-granulated tablets with 20% sorbitol in a particle size of from about 100mu to about 2000mu

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0040472A3 (en) * 1980-05-20 1982-07-21 Mallinckrodt, Inc. Spray dried n-acetyl-p-aminophenol compositions and method for manufacture thereof
EP0186090A3 (en) * 1984-12-24 1987-09-02 Basf Aktiengesellschaft Process for the preparation of an ascorbic-acid granulate
EP0255725A3 (en) * 1986-08-06 1991-01-30 Eisai Co., Ltd. Sustained-release multi-granule tablet
EP0305051A1 (en) * 1987-07-27 1989-03-01 McNeilab, Inc. Orally sustained-release acetaminophen formulation and process to obtain it
WO1994020086A1 (en) * 1993-03-12 1994-09-15 British Technology Group Limited Pharmaceutical compositions comprising paracetamol and l-cysteine or a precursor thereof

Also Published As

Publication number Publication date
FR2150903B1 (enExample) 1975-10-17
CA988424A (en) 1976-05-04
DE2241960A1 (de) 1973-03-15
DK131418C (enExample) 1975-12-01
ZA725791B (en) 1973-05-30
GB1390032A (en) 1975-04-09
DK131418B (da) 1975-07-14
AU4584572A (en) 1974-02-28
DE2241960C2 (de) 1982-02-04

Similar Documents

Publication Publication Date Title
AU2658571A (enExample)
AU2691671A (enExample)
AU2485671A (enExample)
AU3005371A (enExample)
AU2952271A (enExample)
AU2941471A (enExample)
AU2894671A (enExample)
AU2742671A (enExample)
AU2726271A (enExample)
AU2684071A (enExample)
AU2564071A (enExample)
AU2473671A (enExample)
AU1109576A (enExample)
AU3038671A (enExample)
AU2486471A (enExample)
AU3025871A (enExample)
AU2503871A (enExample)
AU2456871A (enExample)
AU2577671A (enExample)
AU2588771A (enExample)
AU2654071A (enExample)
AU2455871A (enExample)
AU2669471A (enExample)
AU2415871A (enExample)
AU2684171A (enExample)

Legal Events

Date Code Title Description
ST Notification of lapse